📂 Drugs
mirvetuximab soravtansine — Definition
mirvetuksimab soravtansin / mirvetuximab soravtansine
Mirvetuksimab soravtansin is an anti-drug conjugat used in the treatment of folate receptor alpha (FRα) positive epithelial over cancer, fallopian tube cancer or primary peritoneal cancer. The drug is taken into the cell by connecting to FRα and kills tumor cells by releasing DM4, a derivative of cytotoxic yeast. It is often indicated in patients with platin-based chemotherapy resistant or multiple treatments. Side effects include visual disorders, fatigue and gastrointestinal symptoms.
Frequently Asked Questions
❓ What is mirvetuksimab soravtansin?
mirvetuksimab soravtansin; mirvetuksimab soravtansin is an anti-drug conjugat used in the treatment of folate receptor alpha (FRα) positive epithelial over cancer, fallopian tube cancer or primary peritoneal cancer. The drug is taken into the cell by connecting to FRα and kills tumor cells by releasing DM4, a derivative of cytotoxic yeast. It is often indicated in patients with platin-based chemotherapy resistant or multiple treatments. Side effects include visual disorders, fatigue and gastrointestinal symptoms.
❓ What is mirvetuximab soravtansine in Turkish?
The Turkish equivalent of "mirvetuximab soravtansine" is mirvetuksimab soravtansin.
❓ Which medical field is mirvetuksimab soravtansin related to?
This term belongs to the Drugs category.